key: cord-0695843-y0mezud1 authors: Fu, Jia; Jia, Qianqian; Zhou, Huaxin; Zhang, Liyang; Wang, Saisai; Liang, Peida; Lv, Yanni; Han, Shengli title: Cell Membrane Chromatography for the Analysis of the Interaction Between Chloroquine and Hydroxychloroquine with ACE2 Receptors date: 2020-11-29 journal: J Chromatogr B Analyt Technol Biomed Life Sci DOI: 10.1016/j.jchromb.2020.122469 sha: 80fe0c0f1239e8f188e05779ed67c0793406fb44 doc_id: 695843 cord_uid: y0mezud1 The recent emergence of the novel pathogenic coronavirus disease 2019 (COVID-19) is responsible for a worldwide pandemic. In sight of this, there has been growing interest in the use of chloroquine (CQ) and hydroxychloroquine (HCQ) as potential treatments. In this study, we use angiotensin converting enzyme 2 (ACE2) over-expressed cell membrane chromatography (CMC) to study the interaction of CQ and HCQ with ACE2 receptor. Both CQ and HCQ were retained on the ACE2/CMC column. Then we analyzed the binding character of CQ and HCQ to ACE2 by CMC frontal analysis, ionic force investigation and competitive binding experiment. Results showed that CQ and HCQ KD values obtained from the CMC frontal analysis method were 8.22(±0.61) × 10-7 M and 11.70(±2.44) × 10-7 M. Compare to CQ, HCQ has the weaker affinity with ACE2. The action force of CQ, HCQ and ACE2 is mainly ionic force. CQ and HCQ have different degrees of competitive binding relationship with ACE2. Our study revealed the interaction of CQ and HCQ with ACE2 receptor, which provides new insights for the use of CQ and HCQ in the treatment of COVID-19. Moreover, this biomimetic drug screening method is expected to open the door for rapid targeting and separating bioactive ingredients active towards ACE2 receptor. Since the first case was reported in Wuhan, China in late December 2019, humans have been threatened by COVID-19 caused by novel coronavirus SARS-CoV-2 [1, 2] . At present, it is generally believed that coronavirus spike glycoprotein (Spike) and receptor ACE2 are the key binding sites for severe acute respiratory syndrome (SARS-CoV). The new coronavirus uses its own Spike protein to interact with the ACE2 protein to invade the human body [3] [4] [5] . Therefore, blocking or antagonizing the ACE2 signal pathway of susceptible cells should be helpful to prevent COVID-19 virus infection [6] . ACE2 is a membrane-bound aminopeptidase that has a vital role in the cardiovascular and immune systems, and the size of ACE2 is 92.4 kDa [7] . In addition, ACE2 has been identified as a functional receptor for coronaviruses, including SARS-CoV and SARS-CoV-2 [8, 9] . Develop inhibitors for ACE2, which can effectively cut off the binding of two proteins, thereby blocking the virus from invading human cells, and preventing infection. So far, there is no effective treatment for COVID-19 drugs. New treatments or vaccines take time to develop. Recently, CQ and its derivative HCQ are considered to be promising repurposed drugs against COVID-19, based on pathophysiological considerations and in vitro results [10, 11] . CQ and HCQ have been used to treat malaria and chronic inflammatory diseases, such as systemic lupus erythematosus and rheumatoid arthritis [12, 13] . It has been reported that CQ interferes with ACE2, inhibits viral spike glycoprotein/ACE2 interaction, and inactivates ACE2 receptor glycosylation, thereby restricting virus entry into target cells [14, 15] . It has been reported that HCQ interferes with the terminal glycosylation of ACE2 [16] , which acts as both SARS-CoV [8] and SARS-CoV-2 [9] membrane receptor, HCQ can play a role in several steps of the coronavirus replication cycle [16] . Therefore, a method is urgently needed to study the interaction between CQ and HCQ with ACE2 receptors. CMC is a new affinity chromatography technology for studying the interaction between receptor and drug, which was created by Professor He Langchong in 1996 [17] . As a biomimetic affinity chromatography, CMC is characterized by the ability of cell membrane stationary phase to retain the three-dimensional configuration and biological activity of membrane receptors to a large extent, and accurately reveal the interaction process between drugs and membrane receptors [18, 19] . CMC has been widely used in the interaction characteristics of compounds and membrane receptors [20, 21] . In this study, the ACE2 over-expression cell membrane chromatography system was established, and the action characteristics of CQ, HCQ and ACE2 were compared. These results will provide valuable information and useful models for a better understanding of drug receptor interactions. For each ACE2/CMC column, the reproducibility was studied by repeatedly injecting CQ and the retention time was used as an indicator. For different ACE2/CMC columns, the reproducibility was tested by injecting CQ into different ACE2/CMC columns. Different drugs acting on different receptors were used to examine the specific selectivity of the ACE2/CMC column. Series concentrations of CQ and HCQ were prepared by saline buffer (50 mM, pH 7.4) were separately flushed through the ACE2/CMC column at a flow rate of 0.2 mL min −1 to generate breakthrough curves. In the CMC model, the K D value is investigated by using frontal analysis with the following equation [22] : linear relationship for a system, and the ratio of slope to intercept is the K D value. According to the theory of SDM-R and formula (2) , linear regression of lg [D] with lgk′ can obtain the information of affinity parameters [24] . Where k' is the capacity factor; lgI is a constant related to the affinity of the Competitive binding experiments were performed using CQ as a site-specific probe, the mobile phase that contained CQ and HCQ were prepared by saline buffer In 293T cells, we over-express ACE2 receptors and Fig. 1A shows the schematic diagram of the construction of ACE2 over-expression 293T cell line. Expression of ACE2 has been investigated with real time PCR and western blotting. The gene expression of ACE2 in 293T transfected with PGMLV-PA6-ACE2 plasmid was about 2500 times higher than that of transfected with empty vector PGMLV-PA6 plasmid 293T (Fig. 1B) . The cell lysates were directly analysed by Western blot. The over expression of ACE2 in 293T cell line was about 2500 times higher than that of NC-293T group (Fig. 1C) . The above results indicate the successful construction of ACE2 over-expressing 293T cells. The retention time of CQ was used to evaluate the reproducibility of ACE2/CMC column. The relative standard deviation (RSD) was 2.6% (n = 5) on a single ACE2/CMC column and 7.3% (n = 3) on different columns. To verify the selectivity of the ACE2/CMC column, benzhexol hydrochloride acting on m-cholinergic receptor, prazosin hydrochloride acting on α 1 receptor, and CQ and HCQ were tested on the ACE2/CMC column and the results are reported in Fig. S1 . Only CQ and HCQ were retained on ACE2/CMC column which suggests the better selectivity of ACE2/CMC column. As illustrated in Fig. 3 , typical breakthrough curves were acquisitioned by frontal analysis. CQ ( Fig. 2A) and HCQ (Fig. 2B) The binding ability of small molecule drugs to replace sodium chloride and ACE2 was investigated by the principle of stoichiometric displacement. According to the theory of solvent metering displacement and formula (2), linear regression of lg[D] with lgk′ to obtain Fig. 3 . The information of affinity parameters was listed in Table 1 . The z values of CQ and HCQ are 2.11 and 1.11 in the presence of different concentrations of sodium chloride, respectively. The action force of CQ, HCQ and ACE2 is mainly ionic force. Compared with HCQ, CQ and ACE2 have a stronger ion force. Then competitive binding experiments were performed. According to the theory of SDM-R and formula (2) , linear regression of lg[D] with lgk′ (Fig. 4) can obtain the information of affinity parameters ( Table 1 ). The magnitude of the z value in the quantitative replacement model can illustrate the possibility of the competitor and ligand acting on the same site of the membrane receptor from another perspective. As shown in Table 1 , the z values of CQ are 0.25 and 1.28 in the presence of different concentrations of displacer CQ and HCQ, respectively, indicating that CQ and HCQ have different degrees of competitive binding relationship with ACE2. The binding mode of CQ and HCQ with ACE2 was studied by molecular docking. As shown in In this study, we established an ACE2/CMC model to analyze the effect of CQ and HCQ binding to ACE2 receptor. Both CQ and HCQ could act on ACE2 receptor. Compare to HCQ, CQ has the stronger affinity with ACE2. The interaction between CQ, HCQ and ACE2 is mainly ionic force. CQ and HCQ have different degrees of competitive binding relationship with ACE2. Our study revealed the interaction of CQ and HCQ with ACE2 receptor, which provides a new insight for the use of CQ and HCQ in the treatment of COVID. Moreover, this biomimetic drug screening method is expected to open the door for rapid targeting and separating bioactive ingredients active towards ACE2 receptor. Pathological findings of COVID-19 associated with acute respiratory distress syndrome Clinical features of patients infected with 2019 nove. coronavirus in Wuhan Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor COVID-19 and the cardiovascular system A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2 ACE2: from vasopeptidase to SARS virus receptor Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2 In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases Characterizing the adverse dermatologic effects of hydroxychloroquine: a systematic review New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection Cell membrane chromatography-a new method for studying the drug-receptor interactions Enzymatic activity and chromatographic characteristics of the cell membrane immobilized on silica surface Coating and fusing cell membranes onto a silica surface and their chromatographic characteristics Determine equilibrium dissociation constant of drug-membrane receptor affinity using the cell membrane chromatography relative standard method Investigation of the binding characteristics between ligands and epidermal growth factor receptor by cell membrane chromatography Characterization of thyroxine albumin binding usinghigh-performance affinity-chromatography. 1. Interactions at the warfarinand indole sites of albumin Stoichiometric displacement theory and its application Retention model for proteins in reversed-phase liquid chromatography We declare that all authors have seen and approved the final version of the manuscript being submitted. We warrant that the article is our original work, hasn't received prior publication and isn't under consideration for publication elsewhere. We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, there is no professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled.